Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Flywheel Secures $54M for Medical AI Imaging Platform
What You Should Know:
Flywheel, a Minneapolis-based medical imaging data and AI platform raises $54M in Series D funding, backed by tech giants including NVIDIA, Microsoft, and more.Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payers, system integrators, AI developers and academic medical centers to get optimum value out of
Read More
Why Interoperability is Key to Successful Digital Pharma Solutions
We are at an interesting crossroads when it comes to pharma and digital health. Several years after the first iteration of digital patient solutions was initially launched, many pharma companies are taking a step back to strategically evaluate how they have performed in practice and the impact they have had on both patient and business outcomes.
Unfortunately, many platforms that pharma companies have either integrated within existing platforms or built have failed to meet those needs – for
Read More
Abbott, American Diabetes Association Launches Therapeutic Nutrition Program for People with Diabetes
What You Should Know:
American Diabetes Association® (ADA) and Abbott announced a collaboration a new collaboration on a pilot therapeutic nutrition program to help people living with Type 2 diabetes.The collaboration aims to understand how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.
Abbott’s $2.6M Grant to Support Diabetes
Abbott is providing a $2.65 million grant
Read More
Oaktree Closes $2.3B Life Sciences Lending Fund
What You Should Know:
Oaktree Capital Management has closed its Life Sciences Lending Fund with a total capital commitment of $2.3B, representing the largest pool of capital ever raised dedicated to the space. Oaktree’s Life Sciences Lending Fund aims to generate attractive risk-adjusted returns by providing bespoke capital solutions to innovative companies across the life sciences sector globally, with a focus on high-growth subsectors, such as biopharma and medical
Read More
AWS Launches $100M Generative AI Center to Accelerate Healthcare, Life Sciences
What You Should Know:
Amazon Web Services, Inc. (AWS) announced an investment of $100M to launch the AWS Generative AI Innovation Center, with healthcare and life sciences as a prioritized industry (alongside Financial Services, Energy & Utilities, Telco, and others). The AWS Generative AI Innovation Center will connect AWS AI and machine learning (ML) experts with customers around the globe to help them envision, design, and launch new generative AI products, services, and
Read More
Feasibility of Cryoablation as a Treatment for Invasive Ductal Carcinoma
Millions of women worldwide are affected by breast cancer, a prevalent form of cancer. For approximately 8 out of 10 cases, invasive ductal carcinoma (IDC) is the most prevalent form of breast cancer. IDC is characterized by cancer cells that have spread beyond the milk ducts into the surrounding breast tissue.
While surgery, chemotherapy, and radiation therapy are commonly used to treat IDC, there is growing interest in alternative treatment options such as cryoablation provided by the ICE3
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Report: Inaccurate Drug Discount Requests Reach Nearly $1B
What You Should Know:
Kalderos, a data infrastructure and analytics company, identified nearly $1B in inaccurate drug discount requests from 2016-Q1 2023 on its drug discount management platform.The report, titled "Mission Critical: Bringing drug discount stakeholders together so patients win," outlines Kalderos' vision for a new paradigm of cooperation among drug discount program stakeholders in which everyone benefits — particularly patients.
Rising Costs of Inaccurate Drug
Read More
2023 Life Sciences Digital Pathology Adoption Survey Report
What You Should Know:
Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Over half of these organizations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics.The “2023
Read More
